| 2026-08-03 | 8-K | 10.2 | Registration Rights Agreement, dated July 30, 2026, by and between the Company and Perceptive. |
|---|
| 2026-08-03 | 8-K | 10.1 | Note Purchase Agreement and Guaranty, dated July 30, 2026, by and among the Company, as issuer, the guarantors party thereto from time to time, the noteholders party thereto from time to time and Perceptive Credit Holdings V, LP, as the administrative agent for the noteholders. |
|---|
| 2026-05-14 | 10-Q | 10.1 | Master Supply Agreement and Statement of Work 1, dated January 21, 2026 and March 17, 2026, respectively, between Autolus Limited and AGC Biologics S.p.A. |
|---|
| 2025-08-12 | 10-Q | 10.2 | Autolus Therapeutics plc - 2025 UK Sharesave Sub-plan |
|---|
| 2025-08-12 | 10-Q | 10.1 | Autolus Therapeutics plc - 2025 Employee Share Purchase Plan |
|---|
| 2025-05-08 | 10-Q | 10.3 | Form of Restricted Stock Unit Grant Notice and Award Agreement for the Autolus Therapeutics plc - 2025 Inducement Plan. |
|---|
| 2025-05-08 | 10-Q | 10.2 | Form of Stock Option Grant Notice and Stock Option Agreement for the Autolus Therapeutics plc - 2025 Inducement Plan. |
|---|
| 2025-05-08 | 10-Q | 10.1 | Autolus Therapeutics plc - 2025 Inducement Plan |
|---|
| 2025-03-20 | 10-K | 10.21 | Exclusive Distribution Agreement, effective as of April 25, 2024, by and between Cardinal Health 105, Inc. and Autolus Inc. |
|---|
| 2025-03-20 | 10-K | 10.20 | Amended Management Incentive Compensation Plan |
|---|
| 2024-11-12 | 10-Q | 10.4 | Amended Management Incentive Compensation Plan |
|---|
| 2024-11-12 | 10-Q | 10.3 | Licence for Alterations, dated September 10, 2024, between Forge Life Sciences Nominee I Limited and Forge Life Sciences Nominee 2 Limited, Autolus Limited and Autolus Therapeutics plc relating to The Nucleus Marshgate, Stevenage. |
|---|
| 2024-11-12 | 10-Q | 10.2 | Deed of Variation, dated September 10, 2024, between Forge Life Sciences Nominee I Limited and Forge Life Sciences Nominee 2 Limited, Autolus Limited and Autolus Therapeutics plc relating to The Nucleus Marshgate, Stevenage. |
|---|
| 2024-11-12 | 10-Q | 10.1 | Capital Contribution Deed, dated September 10, 2024, between Forge Life Sciences Nominee I Limited and Forge Life Sciences Nominee 2 Limited, Autolus Limited and Autolus Therapeutics plc relating to The Nucleus Marshgate, Stevenage. |
|---|
| 2024-03-21 | 10-K | 10.12 | License and Option Agreement between the registrant and BioNTech SE, dated February 6, 2024. |
|---|
| 2024-02-08 | 8-K | 10.3 | Letter Agreement between the registrant and BioNTech SE, dated February 6, 2024 |
|---|
| 2024-02-08 | 8-K | 10.2 | Registration Rights Agreement between the registrant and BioNTech SE, dated February 6, 2024 |
|---|
| 2024-02-08 | 8-K | 10.1 | Securities Purchase Agreement between the registrant and BioNTech SE, dated February 6, 2024 |
|---|
| 2023-11-09 | 10-Q | 10.2 | Amendment 2 to Supply Agreement, dated as of September 27, 2023, by and between Autolus Limited and Miltenyi Biotec B.V. & Co. KG. |
|---|
| 2023-11-09 | 10-Q | 10.1 | Lease Agreement, dated September 19, 2023, between Forge Life Sciences Nominee I Limited and Forge Life Sciences Nominee 2 Limited, Autolus Limited and Autolus Therapeutics plc relating to The Nucleus Marshgate, Stevenage |
|---|